Mandate

Vinge advises Oriflame in relation to the groups change of domicile from Luxembourg to Switzerland

May 11, 2015

Vinge advises Oriflame in connection with the process of changing the group’s domicile from Luxembourg to Switzerland. As part of this process, Oriflame Holding AG, a wholly owned Swiss subsidiary of Oriflame Cosmetics S.A., has announced a share-for-share exchange transaction. The shares of Oriflame Holding are intended to be listed on the main market of Nasdaq Stockholm.

Erik Sjöman and Dain Hård Nevonen (partners, capital markets & public M&A) and Sabina Börjesson and Joel Wahlberg advise Oriflame. Mattias Schömer (partner, tax) and Tora Hansjons provide tax advice.

Related

Vinge has advised Accent Equity VI and the minority shareholders on their divestment of Malte Månson

Vinge has advised Accent Equity VI and the minority shareholders on their divestment of Malte Månson to Citira, a European tire management provider and portfolio company of Norvestor. Headquartered in Stockholm, Malte Månson is an independent service and repair provider for commercial vehicles and operates a network of 28 service workshop locations across Sweden, authorized by brands such as MAN, DAF, IVECO, Mercedes-Benz, Setra, VDL and EVO. Malte Månson has an annual revenue of SEK 800 million and employs over 300 full-time professionals.
June 08, 2026

Vinge advises InArea on entering into a SEK 450 million credit agreement with SEB

InArea's new facilities agreement comprises a term loan and a revolving credit facility, replacing the company's existing facilities. The facilities agreement also includes an option to increase the lending framework through an incremental facility of up to SEK 200 million.
June 03, 2026

Vinge has advised the arrangers in connection with St1 Biokraft’s EUR 260 million financing

Vinge has advised the arrangers, ING Bank N.V., ABN AMRO Bank N.V., DNB Bank ASA, Nordea Bank Abp, OP Corporate Bank plc, Coöperatieve Rabobank U.A., SpareBank 1 Sør-Norge ASA and Swedbank AB, in connection with St1 Biokraft AB’s EUR 260 million financing.
June 03, 2026